Synapse - Nursing

Results (3743)

Risk factors for progression in patients undergoing surveillance for pancreatic cysts

Journal Article

Armstrong, M. T.; Saadat, L. V.; Chou, J. F.; Gönen, M.; Balachandran, V. P.; D'Angelica, M. I.; Drebin, J. A.; Flood, J. A.; Jarnagin, W. R.; Kingham, T. P.; more...
Annals of Surgery (2024)

Fulltext@MSK | Save

The nature of suffering and the goals of nursing. 2nd ed

Book Whole

Oxford University Press (2023)

Fulltext@MSK | Save

The value of collaboration with patient advocacy organizations to enhance initiatives focused on patient-centered care and improve outcomes in chronic lymphocytic leukemia

Meeting Abstract

Deluca, C.; Beyer, M.; Drew, H.; Murray, J.; Massey, J.; Koffman, B.; Battiato, K.; Gribben, J. G.; Lamanna, N.; Russomanno, C.
Blood (2023)

Fulltext@MSK | Save

Outcomes with MEK inhibitor therapy among adults with Langerhans cell histiocytosis (LCH): A multi-institutional study from the Adult LCH Working Group for the Histiocyte Society

Meeting Abstract

Goyal, G.; Acosta Medina, A. A.; Cao, X.; Bossert, D.; Matthew, P. C.; Makras, P.; Abdel-Wahab, O.; Abeykoon, J. P.; Amerikanou, R.; Bach, C.; more...
Blood (2023)

Fulltext@MSK | Save

A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation

Meeting Abstract

Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
Blood (2023)

Fulltext@MSK | Save

Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies

Meeting Abstract

Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
Blood (2023)

Fulltext@MSK | Save

Long-term outcomes with single-agent BRAF-inhibitor therapy in Erdheim-Chester disease

Meeting Abstract

Goyal, G.; Reiner, A.; Bossert, D.; Sigler, A.; Buthorn, J.; Lacouture, M.; Rotemberg, V.; Francis, J. H.; Go, R. S.; Rampal, R. K.; more...
Blood (2023)

Fulltext@MSK | Save

A whole foods plant-based weight loss intervention improves quality of life, metabolic, microbiome and immune profile in MGUS/SMM as well as progression trajectory in a subset - the Nutrivention trial

Meeting Abstract

Shah, U. A.; Castro, F.; Derkach, A.; Fei, T.; Hosszu, K. K.; McAvoy, D.; DeWolf, S.; Cross, J.; Gradissimo, A.; Nwankwo, A.; more...
Blood (2023)

Fulltext@MSK | Save

Phase I study of paxalisib and radiotherapy for CNS disease harboring PI3K pathway mutations: Pilot analysis of circulating tumor DNA for patient eligibility confirmation and post-treatment response

Meeting Abstract

Imber, B.; Ravichandran, V.; Rao, P.; Casanova, H.; Friend, J.; Simpson, J.; Pike, L.; Zinovoy, M.; Mitchell, R.; Chacko, C.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save

Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability

Meeting Abstract

Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
Blood (2023)

Fulltext@MSK | Save